Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8630960 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer
Conditions: Oropharynx Cancer;   Hypopharynx Cancer
Interventions: Drug: Homeodent®;   Drug: 1.4% Sodium Bicarbonate solution

Indicates status has not been verified in more than two years